Gene · 10577
Papers2,338
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,338
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The cholesterol transporter Niemann-Pick C1 facilitates the entry of porcine epidemic diarrhea coronavirus. | J Virol | 2026 | 42262129 | PubTator, text mining | PubMed |
| Pan-filovirus activity of an IGF2-fused monoclonal antibody: Impairment by IGF1R cross-engagement and rescue via IGF2 Y27L mutation. | Virus Res | 2026 | 42191025 | PubTator, text mining | PubMed |
| NPC2 deficiency as a potential target drives malignancy and chemo-resistance in DLBCL. | Biol Direct | 2026 | 42143364 | PubTator, text mining | PubMed |
| Silica nanoparticles suppress porcine oocyte maturation via oxidative stress, metabolic dysfunction, and impaired cholesterol trafficking. | Theriogenology | 2026 | 42105621 | PubTator, text mining | PubMed |
| Sertraline Treatment Can Mimic Niemann-Pick Type C Biomarker Profile: A Diagnostic Pitfall. | Ann Clin Transl Neurol | 2026 | 42037350 | PubTator, text mining | PubMed |
| Genomic insights into photosymbiosis in giant clams and comparisons with coral strategies. | Curr Biol | 2026 | 42034058 | PubTator, text mining | PubMed |
| Current and emerging therapeutic advancements for Niemann-Pick disease type C: where are we now and what does the future hold? | Expert Rev Neurother | 2026 | 42007957 | PubTator, text mining | PubMed |
| A prediction model of gastric cancer based on M2-like tumor-associated macrophage infiltration verified by immunohistochemistry. | Transl Cancer Res | 2026 | 41969477 | PubTator, text mining | PubMed |
| Cardiovascular risk assessment characterized by proteomics in cancer survivors. | Commun Med (Lond) | 2026 | 41946939 | PubTator, text mining | PubMed |
| Mechanistic Basis of Cholesterol Binding and Transfer in NPC2: Insights From Molecular Dynamics Simulations. | Chembiochem | 2026 | 41934663 | PubTator, text mining | PubMed |
| Plasma Proteomic Profiling of Young and Older Adults Identifies Candidate Biomarkers of Biological Aging at the Intersection of Age and Disease. | Aging Cell | 2026 | 41933123 | PubTator, text mining | PubMed |
| Optimization of systemic AAV9 gene therapy in Niemann-Pick disease, type C1 mice. | Life Sci Alliance | 2026 | 41912285 | PubTator, text mining | PubMed |
| Lineage-specific expansion and positive selection of NPC2 genes in the crab spider Ebrechtella tricuspidata and other arachnids. | BMC Genomics | 2026 | 41904369 | PubTator, text mining | PubMed |
| ARPE-19-A Stable Cell Line Expressing a Variant of Unknown Significance in the NPC1 Gene. | Genes (Basel) | 2026 | 41898822 | PubTator, text mining | PubMed |
| Biomarker tests of progression from tuberculosis infection to disease: a systematic review. | Eur Respir Rev | 2026 | 41881453 | PubTator, text mining | PubMed |
| Early Diagnosis of Nieman-Pick Disease Type C and Rapid Response of Gelastic Cataplexy to Treatment With N-Acetyl-L-Leucine: A Case Report. | Am J Case Rep | 2026 | 41851921 | PubTator, text mining | PubMed |
| NPC2 suppresses osteolytic metastasis in lung adenocarcinoma via the AKT/mTOR pathway and tumor-osteoclast crosstalk. | iScience | 2026 | 41816293 | PubTator, text mining | PubMed |
| Case Report: Interleukin-23 blockade achieves sustained remission in Niemann-Pick type C-associated Crohn's disease refractory to anti-tumor necrosis factor therapy. | Front Immunol | 2026 | 41798938 | PubTator, text mining | PubMed |
| A red blood cell-based antigen delivery system to facilitate T cell epitope presentation to promote peripheral tolerance to ADAMTS13 in immune-mediated thrombotic thrombocytopenic purpura. | Res Pract Thromb Haemost | 2026 | 41798267 | PubTator, text mining | PubMed |
| Small Molecules to Elevate Rab7-GTPase Activity and Lower Cholesterol Accumulation in Niemann-Pick Type C Disease. | Pharm Res | 2026 | 41776152 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10577/papers?page=2